tiprankstipranks
Affimed Therapeutics (AFMD)
:AFMD
US Market

Affimed (AFMD) Financial Statements

Compare
846 Followers

Affimed Financial Overview

Affimed's market cap is currently $15.53M. The company's EPS TTM is $-3.64; its P/E ratio is ―; Affimed is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.85. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 8.28M€ 41.35M€ 40.37M€ 28.36M€ 21.39M
Gross Profit€ 8.28M€ 41.35M€ 40.37M€ 28.36M€ 21.39M
Operating Income€ -106.66M€ -88.12M€ -64.03M€ -34.72M€ -32.38M
EBITDA€ -102.38M€ -81.47M€ -64.01M€ -34.23M€ -30.97M
Net Income€ -105.94M€ -86.00M€ -57.52M€ -41.37M€ -32.37M
Balance Sheet
Cash & Short-Term Investments€ 72.90M€ 190.29M€ 197.63M€ 146.85M€ 104.14M
Total Assets€ 97.16M€ 200.51M€ 225.13M€ 175.72M€ 112.36M
Total Debt€ 19.35M€ 18.19M€ 18.69M€ 1.30M€ 3.19M
Net Debt€ -19.18M€ -172.10M€ -178.94M€ -145.56M€ -92.05M
Total Liabilities€ 39.35M€ 47.60M€ 89.18M€ 103.73M€ 73.69M
Stockholders' Equity€ 57.81M€ 152.91M€ 135.95M€ 71.99M€ 38.67M
Cash Flow
Free Cash Flow€ -114.00M€ -105.59M€ -90.44M€ -19.84M€ -30.53M
Operating Cash Flow€ -110.27M€ -104.89M€ -86.59M€ -19.40M€ -29.06M
Investing Cash Flow€ -36.06M€ 5.61M€ -3.85M€ 8.01M€ 4.34M
Financing Cash Flow€ -6.22M€ 88.56M€ 133.58M€ 69.25M€ 26.04M
Currency in EUR

Affimed Earnings and Revenue History

Affimed Debt to Assets

Affimed Cash Flow

Affimed Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis